Tri Locum Partners as of Dec. 31, 2021
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 40 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 9.6 | $24M | 180k | 135.40 | |
| Eli Lilly & Co. (LLY) | 8.5 | $22M | 79k | 276.22 | |
| Edwards Lifesciences (EW) | 7.5 | $19M | 147k | 129.55 | |
| Argenx Se Sponsored Adr (ARGX) | 6.7 | $17M | 48k | 350.20 | |
| Chemocentryx | 6.3 | $16M | 436k | 36.41 | |
| Apellis Pharmaceuticals (APLS) | 5.9 | $15M | 318k | 47.28 | |
| The Beauty Health Company Com Cl A (SKIN) | 5.5 | $14M | 580k | 24.16 | |
| Kezar Life Sciences (KZR) | 4.8 | $12M | 733k | 16.72 | |
| Protagonist Therapeutics (PTGX) | 4.2 | $11M | 314k | 34.20 | |
| Adicet Bio (ACET) | 4.0 | $10M | 583k | 17.49 | |
| United Therapeutics Corporation (UTHR) | 3.9 | $9.9M | 46k | 216.08 | |
| Inhibrx (INBX) | 3.7 | $9.3M | 213k | 43.67 | |
| Seagen | 3.6 | $9.3M | 60k | 154.60 | |
| Fate Therapeutics (FATE) | 3.3 | $8.3M | 142k | 58.51 | |
| Bellus Health Com New | 3.1 | $7.9M | 976k | 8.05 | |
| Evolent Health Cl A (EVH) | 2.5 | $6.2M | 225k | 27.67 | |
| Stevanato Group S P A Ord Shs (STVN) | 2.0 | $5.1M | 227k | 22.45 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.6 | $4.2M | 90k | 46.61 | |
| X4 Pharmaceuticals (XFOR) | 1.4 | $3.6M | 1.6M | 2.29 | |
| Science 37 Holdings | 1.3 | $3.4M | 271k | 12.47 | |
| Biohaven Pharmaceutical Holding | 1.3 | $3.4M | 24k | 137.81 | |
| Catalent (CTLT) | 1.2 | $3.0M | 24k | 128.02 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.8 | $2.0M | 24k | 84.08 | |
| Abiomed | 0.7 | $1.9M | 5.2k | 359.26 | |
| Rapt Therapeutics (RAPT) | 0.7 | $1.8M | 48k | 36.73 | |
| Tricida | 0.6 | $1.6M | 170k | 9.56 | |
| Cytokinetics Com New (CYTK) | 0.6 | $1.5M | 33k | 45.57 | |
| Novavax Com New Call Option (NVAX) | 0.6 | $1.5M | 11k | 143.11 | |
| 1life Healthcare | 0.6 | $1.5M | 85k | 17.57 | |
| Intra Cellular Therapies (ITCI) | 0.5 | $1.4M | 26k | 52.34 | |
| American Well Corp Cl A (AMWL) | 0.5 | $1.4M | 225k | 6.04 | |
| Cano Health Com Cl A | 0.5 | $1.3M | 142k | 8.91 | |
| Vir Biotechnology Put Option (VIR) | 0.5 | $1.3M | 30k | 41.87 | |
| Scholar Rock Hldg Corp (SRRK) | 0.4 | $1.0M | 41k | 24.85 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $806k | 55k | 14.54 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $782k | 25k | 31.23 | |
| Femasys (FEMY) | 0.2 | $568k | 146k | 3.90 | |
| DURECT Corporation | 0.0 | $26k | 26k | 0.99 | |
| Aspira Womens Health | 0.0 | $19k | 11k | 1.75 | |
| Athersys | 0.0 | $18k | 19k | 0.93 |
